Global Oncolytic Virus Immunotherapy Market & Clinical Trials Insight - A USD 1.50 Billion+ Market Opportunity by 2030
14 mai 2024 08h50 HE
|
Research and Markets
Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Immunotherapy Market Opportunity & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's offering....
Global, Oncolytic Virus Therapy Research Report 2024: Market to Reach $53.06 Billion by 2028, Driven by Strategic Partnerships and Rising Awareness
04 mars 2024 11h02 HE
|
Research and Markets
Dublin, March 04, 2024 (GLOBE NEWSWIRE) -- The "Oncolytic Virus Therapy Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028" report has been added to ...
Global Oncolytic Virus Therapy Market to Reach Value of USD 2,041.05 Million by 2032 | Emergen Research
02 nov. 2023 09h30 HE
|
Emergen Research
Vancouver, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The global oncolytic virus therapy market size is expected to reach USD 2,041.05 Million at a steady CAGR of 23.9% in 2032, according to latest analysis...
Global Oncolytic Virus Therapy Market Trends and Opportunities 2023-2027: Insights for HSV-based Oncolytic Virus, Adenovirus-based Oncolytic Virus, Reovirus, Poxviruses, NDV, and Other Therapy Types
01 nov. 2023 08h08 HE
|
Research and Markets
Dublin, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Therapy Market 2023" report has been added to ResearchAndMarkets.com's offering. The global oncolytic virus therapy market is...
Global T-Cell Immunotherapy Market Report 2023-2028: Increasing Developments in CAR T-Cell Therapy for Solid Tumors Fuels Growth
01 juin 2023 05h18 HE
|
Research and Markets
Dublin, June 01, 2023 (GLOBE NEWSWIRE) -- The "Global T-Cell Immunotherapy Market (2023-2028) by Therapy Type, Mechanism of Action, Product Class, Indication, Modality, and Geography, Competitive...
Global Oncolytic Virus Therapy Market Report 2023: Increase in Clinical Trials and Approval of New Virus Therapies Boosts Growth
11 mai 2023 07h33 HE
|
Research and Markets
Dublin, May 11, 2023 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Therapy Market Outlook to 2035" report has been added to ResearchAndMarkets.com's offering.The global oncolytic virus therapy...
Insights on the Oncolytic Virus Immunotherapy Global Market to 2028 - Featuring Key Players AdCure Bio, BioVex, Calidi Biotherapeutics, Takara Bio and Others
13 déc. 2022 06h08 HE
|
Research and Markets
Dublin, Dec. 13, 2022 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Immunotherapy Market and Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. The global...
Global T-Cell Immunotherapy Market Report to 2027 - Featuring Atara Biotherapeutics, Autolus and bluebird bio Among Others
21 juil. 2022 07h18 HE
|
Research and Markets
Dublin, July 21, 2022 (GLOBE NEWSWIRE) -- The "T-Cell Immunotherapy Market Intelligence Report - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The Global...
Global Oncolytic Virus Therapy Market to Touch a Revenue of USD 1062.7 Million by 2028; Increasing Investments for Cancer Research and Rising Incidences of Cancer to Accelerate Market Growth
07 déc. 2021 07h17 HE
|
Research Nester
New York, Dec. 07, 2021 (GLOBE NEWSWIRE) -- According to the statistics by the World Health Organization (WHO), cancer-related deaths recorded close to 10 Million in the year 2020. Moreover, amongst...
Global $1060 Million Oncolytic Virus Therapy Markets Outlook 2021-2028 by Therapy Type, Virus Type, Indication, Demography, End-user
01 déc. 2021 05h08 HE
|
Research and Markets
Dublin, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Therapy Market Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The market is anticipated to garner a...